SEGMENT INFORMATION (Tables)

6 Months Ended

Apr. 30, 2017



	Three months ended April 30, 2017
	DPS	PDS	DSS	Other		Intersegment Eliminations		Total
	$	$	$	$		$		$
Revenues	297.2	57.8	129.2	—		(0.8	)	483.4
Adjusted EBITDA	77.4	18.4	26.1	(27.5	)	(0.2	)	94.2
Depreciation and amortization	15.4	1.9	16.1	0.9				34.3
Capital expenditures	19.5	1.7	11.6	7.4				40.2



	Three months ended April 30, 2016
	DPS	PDS	DSS	Other		Intersegment Eliminations		Total
	$	$	$	$		$		$
Revenues	287.4	53.4	127.9	—		(0.1	)	468.6
Adjusted EBITDA	72.7	16.7	30.8	(22.2	)			98.0
Depreciation and amortization	14.9	1.3	10.2	0.6				27.0
Capital expenditures	11.7	5.9	9.0	4.3				30.9



	Six months ended April 30, 2017
	DPS	PDS	DSS	Other		Intersegment Eliminations		Total
	$	$	$	$		$		$
Revenues	572.4	110.1	259.1	—		(0.8	)	940.8
Adjusted EBITDA	138.8	34.7	58.1	(54.7	)	(0.2	)	176.7
Depreciation and amortization	30.7	3.7	25.8	1.7				61.9
Capital expenditures	56.4	3.1	29.5	10.2				99.2



	Six months ended April 30, 2016
	DPS	PDS	DSS	Other		Intersegment Eliminations		Total
	$	$	$	$		$		$
Revenues	545.9	101.9	226.8	—		(0.1	)	874.5
Adjusted EBITDA	127.8	30.5	45.6	(46.9	)			157.0
Depreciation and amortization	29.7	2.5	20.1	1.2				53.5
Capital expenditures	56.7	15.6	16.3	6.5				95.1

Reconciliation of Adjusted EBITDA

Below is a reconciliation of Adjusted EBITDA to its most comparable U.S. GAAP measure.



	Three months ended April 30,				Six months ended April 30,
	2017		2016		2017		2016
	$		$		$		$
Total Adjusted EBITDA	94.2		98.0		176.7		157.0
Depreciation and amortization	(34.3	)	(27.0	)	(61.9	)	(53.5	)
Repositioning expenses ⁽¹⁾	(2.2	)	(1.3	)	(3.5	)	(2.5	)
Acquisition and integration costs	(8.1	)	(7.6	)	(11.6	)	(10.2	)
Interest expense, net	(30.8	)	(42.6	)	(59.0	)	(86.4	)
Benefit from (provision for) income taxes	1.5		(0.7	)	22.8		—
Refinancing expenses	(6.3	)	—		(6.3	)	—
Operational initiatives related consulting costs	(1.4	)	(1.9	)	(2.5	)	(3.3	)
IPO costs	—		(0.4	)	—		(0.8	)
Acquisition related litigation expenses	(3.7	)	(0.9	)	(6.0	)	(1.9	)
Stock based compensation expense	(7.0	)	(2.0	)	(11.0	)	(3.0	)
FDA remediation costs	—		(10.1	)	—		(18.5	)
Environmental remediation costs	—		—		(3.7	)	—
Bargain purchase gain	26.4		—		26.4		—
Other	(0.7	)	(1.6	)	(4.5	)	5.0
Net income (loss) from continuing operations	27.6		1.9		55.9		(18.1	)

(1) Repositioning expenses for the three and six months ended April 30, 2017 includes $0.4 million and $1.1 million of inventory reserves related to the Swindon wind down recorded in cost of goods sold.

Schedule of Revenue, Capital Assets and Goodwill, by Country

As illustrated in the table below, revenues are attributed to countries based on the location of the customer's billing address, capital assets are attributed to the country in which they are located and goodwill is attributed to the country in which the entity to which the goodwill pertains is located:



	Three months ended April 30, 2017
	Canada	US*	Europe	Other**	Total
	$	$	$	$	$
Revenues	4.2	282.8	167.9	28.5	483.4

* Includes Puerto Rico

** Primarily includes Japan



	Three months ended April 30, 2016
	Canada	US*	Europe	Other**	Total
	$	$	$	$	$
Revenues	5.1	317.6	124.8	21.1	468.6

* Includes Puerto Rico

** Primarily includes Japan



	As of and for the six months ended April 30, 2017
	Canada	US*	Europe	Other**	Total
	$	$	$	$	$
Revenues	11.2	564.7	320.7	44.2	940.8
Capital Assets	100.1	687.6	367.5	14.1	1,169.3
Goodwill	2.5	269.4	7.4	2.1	281.4

* Includes Puerto Rico

** Other revenues primarily include Japan



	As of and for the six months ended April 30, 2016
	Canada	US*	Europe	Other**	Total
	$	$	$	$	$
Revenues	12.4	589.4	236.7	36.0	874.5
Capital Assets	100.8	487.3	341.6	16.1	945.8
Goodwill	2.8	269.4	7.7	2.2	282.1

* Includes Puerto Rico

** Other revenues primarily include Japan